Role of the chemokines CCL3/MIP-1α and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice

被引:40
作者
Barcelos, Luciola S. [1 ]
Coelho, Amanda M. [1 ,2 ]
Russo, Remo C. [2 ]
Guabiraba, Rodrigo [2 ]
Souza, Adriano L. S. [2 ]
Bruno-Lima, Guilherme, Jr. [1 ]
Proudfoot, Amanda E. I. [3 ]
Andrade, Silvia P. [1 ]
Teixeira, Mauro M. [2 ]
机构
[1] Univ Fed Minas Gerais, Dept Fisiol & Biofis, ICB, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Bioquim & Imunol, ICB, BR-31270901 Belo Horizonte, MG, Brazil
[3] Merck Serono Geneva Res Ctr, Geneva, Switzerland
关键词
Inflammation; Neovascularization; Chemokines; Met-RANTES; VASCULAR ENDOTHELIAL-CELLS; IN-VIVO; WOUND REPAIR; NEOINTIMA FORMATION; KAPOSIS-SARCOMA; VMIP-II; RANTES; CC; EXPRESSION; RECEPTOR;
D O I
10.1016/j.mvr.2009.04.009
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: We examined the potential contribution of CCL3 and CCL5 to inflammatory angiogenesis in mice. Methods: Polyester-polyurethane sponges were implanted in mice and blood vessel counting and hemoglobin, myeloperoxidase and N-acetylglucosaminidase measurements used as indexes for vascularization, neutrophil and macrophage accumulation, respectively. Results: CCL3 and CCL5 were expressed throughout the observation period. Exogenous CCL3 enhanced angiogenesis in WT, but angiogenesis proceeded normally in CCL3(-/-) mice, suggesting that endogenous CCL3 is not critical for sponge-induced angiogenesis in mice. CCL5 expression was detected at day 1, but levels significantly increased thereafter. Exogenous CCL5 reduced angiogenesis in WT mice possible via CCR5 as CCL5 was without an effect in CCR5(-/-) mice. Treatment of WT with the CCR1/CCR5 antagonist, Met-RANTES, prevented neutrophil and macrophage accumulation, but enhanced sponge vascularization. Conclusion: Thus, endogenous CCL3 appears not to play a role in driving sponge-induced inflammatory angiogenesis in mice. The effects of CCL5 were anti-angiogenic and appeared to be mediated via activation of CCR5. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:148 / 154
页数:7
相关论文
共 52 条
[11]   Murine chemokine CXCL2/KC is a surrogate marker for angiogenic activity in the inflammatory granulation tissue [J].
Belo, AV ;
Leles, F ;
Barcelos, LS ;
Ferreira, MAND ;
Bakhle, YS ;
Teixeira, MM ;
Andrade, SP .
MICROCIRCULATION, 2005, 12 (07) :597-606
[12]   CXC and CC chemokine receptors on coronary and brain endothelia [J].
Berger, O ;
Gan, XH ;
Gujuluva, C ;
Burns, AR ;
Sulur, G ;
Stins, M ;
Way, D ;
Witte, M ;
Weinand, M ;
Said, J ;
Kim, KS ;
Taub, D ;
Graves, MC ;
Fiala, M .
MOLECULAR MEDICINE, 1999, 5 (12) :795-805
[13]   Analysis of the role of chemokines in angiogenesis [J].
Bernardini, G ;
Ribatti, D ;
Spinetti, G ;
Morbidelli, L ;
Ziche, M ;
Santoni, A ;
Capogrossi, MC ;
Napolitano, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 273 (1-2) :83-101
[14]  
Bonecchi R, 1999, J IMMUNOL, V162, P474
[15]   Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines [J].
Boshoff, C ;
Endo, Y ;
Collins, PD ;
Takeuchi, Y ;
Reeves, JD ;
Schweickart, VL ;
Siani, MA ;
Sasaki, T ;
Williams, TJ ;
Gray, PW ;
Moore, PS ;
Chang, Y ;
Weiss, RA .
SCIENCE, 1997, 278 (5336) :290-294
[16]   Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice [J].
Bradshaw, AD ;
Reed, MJ ;
Carbon, JG ;
Pinney, E ;
Brekken, RA ;
Sage, EH .
WOUND REPAIR AND REGENERATION, 2001, 9 (06) :522-530
[17]  
Campos PP, 2006, HISTOL HISTOPATHOL, V21, P1263, DOI 10.14670/HH-21.1263
[18]   Mechanisms of wound healing responses in lupus-prone New Zealand White mouse strain [J].
Campos, Paula P. ;
Bakhle, Yeshwant S. ;
Andrade, Silvia P. .
WOUND REPAIR AND REGENERATION, 2008, 16 (03) :416-424
[19]   In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II [J].
Chen, SH ;
Bacon, KB ;
Li, L ;
Garcia, GE ;
Xia, YY ;
Lo, D ;
Thompson, DA ;
Siani, MA ;
Yamamoto, T ;
Harrison, JK ;
Feng, LL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) :193-198
[20]   Cancer immunotherapy with chemoattractant peptides [J].
Coscia, M ;
Biragyn, A .
SEMINARS IN CANCER BIOLOGY, 2004, 14 (03) :209-218